Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Biegus

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
European Journal of Heart Failure|October 31, 2023
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failureJozine M Ter Maaten, Alexandre Mebazaa, Beth Davison, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2024
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF studyJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
ESC Heart Failure|February 12, 2025
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF studyAlbertino Damasceno, Hadiza Saidu, Gad Cotter, et al.
European Journal of Heart Failure|September 20, 2023
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trialOvidiu Chioncel, Beth Davison, Marianna Adamo, et al.
European Journal of Heart Failure|May 16, 2023
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trialKamilė Čerlinskaitė-Bajorė, Carolyn S P Lam, Karen Sliwa, et al.
Circulation. Heart Failure|March 6, 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF TrialJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
European Journal of Heart Failure|October 31, 2023
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failureJozine M Ter Maaten, Alexandre Mebazaa, Beth Davison, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2024
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF studyJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
ESC Heart Failure|February 12, 2025
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF studyAlbertino Damasceno, Hadiza Saidu, Gad Cotter, et al.
European Journal of Heart Failure|September 20, 2023
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trialOvidiu Chioncel, Beth Davison, Marianna Adamo, et al.
European Journal of Heart Failure|May 16, 2023
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trialKamilė Čerlinskaitė-Bajorė, Carolyn S P Lam, Karen Sliwa, et al.
Circulation. Heart Failure|March 6, 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF TrialJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
Pageof 21